For decades, the "amyloid hypothesis" has dominated neurobiology, yet drugs targeting plaque clearance have yielded mixed clinical success [1] [2]. A paradigm shift is now underway, focusing on geroscience: the idea that targeting biological aging itself is the most effective way to prevent Alzheimer’s disease (AD) [3]. At the center of this movement is rapamycin…

The landscape of chronic illness treatment is shifting as researchers move beyond mere symptom management toward addressing the biological roots of exhaustion. As we move through 2026, a clear trend has emerged: rapamycin, once known primarily as a transplant drug and longevity "miracle," is being repurposed as a precision tool for patients battling Long COVID…

"They might increase lifespan by a little bit or they might increase it by a lot,” says Tahlia Fulton at the University of Sydney in Australia. What is Rapamycin and How Did Its Role in Aging Research Begin? The quest to extend healthy human lifespan has long captivated biomedical science, yet few interventions have generated as much…

Navigating the landscape of geroprotectors requires a shift from traditional disease treatment to proactive biological optimization. Rapamycin dosing for longevity has moved beyond theoretical mouse models and into the clinics of specialty practitioners, yet the transition from a daily transplant drug to an intermittent anti-aging protocol requires precision to maximize autophagy while avoiding metabolic pitfalls.…

Can a drug originally used in organ transplant medicine hold the key to preventing Alzheimer’s disease? As we move into 2025, Rapamycin has transitioned from a niche "longevity molecule" to a primary subject of intense clinical investigation for dementia. Rapamycin is an FDA-approved mTOR inhibitor that researchers believe may slow the biological processes of aging…

A medication once reserved for preventing organ rejection, rapamycin is now gaining momentum in the field of longevity and rapamycin for anti-aging research. Initially created as an immunosuppressive drug, rapamycin is now being studied for its potential to slow aging and support rapamycin lifespan extension in humans. With growing scientific support pointing to its possible…